Am Fam Physician. 2012 Aug 15;86(4):318.

In the article “Prevention of Perinatal Group B Streptococcal Disease: Updated CDC Guideline” (July 1, 2012, page 59), the third to last sentence of the abstract (page 59) incorrectly stated that clindamycin is recommended in persons at serious risk of anaphylaxis if susceptibility is unknown. However, vancomycin, not clindamycin, is recommended in these persons. The sentence should have read: “For those at serious risk of anaphylaxis, clindamycin is recommended if the organism is susceptible, and vancomycin is recommended if there is clindamycin resistance or if susceptibility is unknown.” The online version of this article has been corrected.


Copyright © 2012 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Sep 2021

Access the latest issue of American Family Physician

Read the Issue

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article